SMTL ID : 3og7.1 (1 other biounit)

B-Raf Kinase V600E oncogenic mutant in complex with PLX4032

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.45 Å

Oligo State

monomer

Ligands

1 x 032: N-(3-{[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl}-2,4-difluorophenyl)propane-1-sulfonamide(Non-covalent)

032.1: 16 residues within 4Å: Chain A: I.32, V.40, A.50, K.52, L.74, L.83, I.96, T.98, Q.99, W.100, C.101, F.152, G.162, D.163, F.164, G.165 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:I.32, A:K.52, A:L.74, A:I.96, A:T.98, A:W.100, A:F.164 Hydrogen bonds: A:T.98, A:Q.99, A:C.101, A:D.163, A:F.164, A:G.165 pi-Cation interactions: A:K.52

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bollag, G. et al., Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature (2010)

Release Date

2010-09-22

Peptides

AKAP9-BRAF fusion protein: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

AKAP9-BRAF fusion protein

Related Entries With Identical Sequence